Eva Díaz

523 total citations
15 papers, 143 citations indexed

About

Eva Díaz is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Eva Díaz has authored 15 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Eva Díaz's work include Cancer Genomics and Diagnostics (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Eva Díaz is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Eva Díaz collaborates with scholars based in Spain, United States and Palestinian Territory. Eva Díaz's co-authors include Gema Moreno‐Bueno, Alicia Abalo, Laura Muinelo‐Romay, Laura Sánchez, Lorena Alonso‐Alconada, Alejandro Rojo‐Sebastián, Juan F. Garcı́a, Alba Ferreirós, Carlos Montalbán and Rafael López‐López and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Eva Díaz

13 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Díaz Spain 6 57 56 53 53 19 15 143
Thais Maloberti Italy 6 54 0.9× 38 0.7× 29 0.5× 62 1.2× 8 0.4× 40 164
Claire H. Barnes Singapore 2 86 1.5× 38 0.7× 19 0.4× 55 1.0× 16 0.8× 2 137
Laëtitia Nebot-Bral France 5 34 0.6× 49 0.9× 64 1.2× 115 2.2× 28 1.5× 6 166
Philippa Dudley United Kingdom 4 100 1.8× 42 0.8× 27 0.5× 46 0.9× 10 0.5× 5 154
Phuong Dinh Australia 7 57 1.0× 36 0.6× 22 0.4× 86 1.6× 11 0.6× 8 166
Jianli Zhao China 6 100 1.8× 66 1.2× 24 0.5× 110 2.1× 12 0.6× 19 252
A. Papadopoulos United Kingdom 7 50 0.9× 44 0.8× 21 0.4× 31 0.6× 29 1.5× 14 139
K Gugała Poland 5 112 2.0× 36 0.6× 22 0.4× 116 2.2× 9 0.5× 9 201
E. Im United States 6 48 0.8× 15 0.3× 44 0.8× 134 2.5× 25 1.3× 17 194
Johanna Kondelin Finland 6 144 2.5× 72 1.3× 111 2.1× 77 1.5× 12 0.6× 8 225

Countries citing papers authored by Eva Díaz

Since Specialization
Citations

This map shows the geographic impact of Eva Díaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Díaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Díaz more than expected).

Fields of papers citing papers by Eva Díaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Díaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Díaz. The network helps show where Eva Díaz may publish in the future.

Co-authorship network of co-authors of Eva Díaz

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Díaz. A scholar is included among the top collaborators of Eva Díaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Díaz. Eva Díaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Solórzano, José Luis, Mónica García‐Cosío, Laura Cereceda, et al.. (2024). Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma. Scientific Reports. 14(1). 710–710. 3 indexed citations
2.
Rodrigo, Juan P., Gema Moreno‐Bueno, Paloma Lequerica–Fernández, et al.. (2024). Tumor-Intrinsic Perinuclear LOXL2: Prognostic Relevance and Relationship with YAP1 Activation Status in Oral Squamous Cell Carcinoma. Pathobiology. 91(6). 422–433.
3.
Solórzano, José Luis, Edwin R. Parra, Luisa M. Solis, et al.. (2024). Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma. OncoImmunology. 13(1). 2388304–2388304. 1 indexed citations
4.
Moiola, Cristian P., Ana Vilar, Juan Cueva, et al.. (2023). Noninvasive detection of microsatellite instability in patients with endometrial cancer. International Journal of Cancer. 152(10). 2206–2217. 8 indexed citations
5.
Monzón, Sara, Laura Cereceda, Eva Díaz, et al.. (2023). Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG‐PET/CT. SHILAP Revista de lepidopterología. 5(1). 70–75. 6 indexed citations
6.
Abalo, Alicia, Ana Vilar, Eva Díaz, et al.. (2022). Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report. International Journal of Molecular Sciences. 23(15). 8539–8539. 5 indexed citations
7.
Molina-Crespo, Ángela, Carmen Ramos, Lidia Martínez, et al.. (2022). Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation. Journal of Experimental & Clinical Cancer Research. 41(1). 285–285. 26 indexed citations
8.
Monzón, Sara, José Luis Solórzano, Eva Díaz, et al.. (2022). JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells. Blood Advances. 7(15). 4135–4147. 5 indexed citations
9.
García‐Estévez, Laura, Isabel Calvo, Eva Díaz, et al.. (2021). Predictive Role of Leptin Receptor (Ob-R) Overexpression in Patients with Early Breast Cancer Receiving Neoadjuvant Systemic Treatment. Cancers. 13(13). 3269–3269. 5 indexed citations
10.
Cabezas‐Sainz, Pablo, Lorena Alonso‐Alconada, Alba Ferreirós, et al.. (2020). Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer. Cells. 9(5). 1218–1218. 28 indexed citations
11.
Díaz, Eva, Cristian P. Moiola, Lorena Alonso‐Alconada, et al.. (2020). Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer. Journal of Clinical Medicine. 9(2). 585–585. 21 indexed citations
12.
Jimenez‐Rolando, Belén, Susana Noval, Eva Díaz, et al.. (2017). La secuenciación masiva (NGS) como método diagnóstico en la enfermedad de Stargardt. Archivos de la Sociedad Española de Oftalmología. 93(3). 119–125. 4 indexed citations
13.
Mata, Elena, Antonio Díaz‐López, Ana M. Martín‐Moreno, et al.. (2017). Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets. Oncotarget. 8(67). 111386–111395. 27 indexed citations
14.
Jimenez‐Rolando, Belén, Susana Noval, Eva Díaz, et al.. (2017). Next generation sequencing in the diagnosis of Stargardt's disease. Archivos de la Sociedad Española de Oftalmología (English Edition). 93(3). 119–125. 4 indexed citations
15.
Louvet, Alexandre, Eva Díaz, Frédéric Texier, et al.. (2006). 92 Prediction of mortality in severe alcoholic hepatitis: Validation of lille model and comparison to other prognostic scores. Journal of Hepatology. 44. S41–S41.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026